nodes	percent_of_prediction	percent_of_DWPC	metapath
Melphalan—SLC7A5—Mycophenolic acid—Mycophenolate mofetil—systemic scleroderma	0.0214	0.829	CbGdCrCtD
Melphalan—SLC7A5—connective tissue—systemic scleroderma	0.00429	0.156	CbGeAlD
Melphalan—SLC7A5—smooth muscle tissue—systemic scleroderma	0.00393	0.143	CbGeAlD
Melphalan—SLC7A5—skin of body—systemic scleroderma	0.00388	0.141	CbGeAlD
Melphalan—SLC7A5—digestive system—systemic scleroderma	0.0031	0.113	CbGeAlD
Melphalan—SLC7A5—tendon—systemic scleroderma	0.00295	0.108	CbGeAlD
Melphalan—SLC7A5—Desoximetasone—Mometasone—systemic scleroderma	0.00286	0.111	CbGdCrCtD
Melphalan—SLC22A3—connective tissue—systemic scleroderma	0.00267	0.0971	CbGeAlD
Melphalan—SLC7A5—lung—systemic scleroderma	0.00259	0.0943	CbGeAlD
Melphalan—SLC22A3—smooth muscle tissue—systemic scleroderma	0.00244	0.0888	CbGeAlD
Melphalan—SLC22A3—lung—systemic scleroderma	0.00161	0.0586	CbGeAlD
Melphalan—SLC7A5—Desoximetasone—Prednisone—systemic scleroderma	0.00156	0.0604	CbGdCrCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.00123	0.0013	CcSEcCtD
Melphalan—Leukopenia—Leflunomide—systemic scleroderma	0.00123	0.0013	CcSEcCtD
Melphalan—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00123	0.0013	CcSEcCtD
Melphalan—Mediastinal disorder—Lisinopril—systemic scleroderma	0.00122	0.00129	CcSEcCtD
Melphalan—Paraesthesia—Captopril—systemic scleroderma	0.00122	0.00129	CcSEcCtD
Melphalan—Dyspnoea—Captopril—systemic scleroderma	0.00121	0.00128	CcSEcCtD
Melphalan—Neoplasm—Methotrexate—systemic scleroderma	0.00121	0.00128	CcSEcCtD
Melphalan—Mouth ulceration—Methotrexate—systemic scleroderma	0.00121	0.00128	CcSEcCtD
Melphalan—Bladder pain—Methotrexate—systemic scleroderma	0.00121	0.00128	CcSEcCtD
Melphalan—Arrhythmia—Lisinopril—systemic scleroderma	0.00121	0.00128	CcSEcCtD
Melphalan—Anaemia—Mycophenolic acid—systemic scleroderma	0.00121	0.00128	CcSEcCtD
Melphalan—Cough—Leflunomide—systemic scleroderma	0.0012	0.00126	CcSEcCtD
Melphalan—Alopecia—Lisinopril—systemic scleroderma	0.0012	0.00126	CcSEcCtD
Melphalan—Dyspepsia—Captopril—systemic scleroderma	0.0012	0.00126	CcSEcCtD
Melphalan—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.00119	0.00126	CcSEcCtD
Melphalan—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.00119	0.00125	CcSEcCtD
Melphalan—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.00119	0.00125	CcSEcCtD
Melphalan—Decreased appetite—Captopril—systemic scleroderma	0.00118	0.00125	CcSEcCtD
Melphalan—Infection—Azathioprine—systemic scleroderma	0.00118	0.00124	CcSEcCtD
Melphalan—Urinary tract disorder—Mycophenolate mofetil—systemic scleroderma	0.00117	0.00124	CcSEcCtD
Melphalan—Leukopenia—Mycophenolic acid—systemic scleroderma	0.00117	0.00124	CcSEcCtD
Melphalan—Fatigue—Captopril—systemic scleroderma	0.00117	0.00124	CcSEcCtD
Melphalan—Chest pain—Leflunomide—systemic scleroderma	0.00117	0.00123	CcSEcCtD
Melphalan—Myalgia—Leflunomide—systemic scleroderma	0.00117	0.00123	CcSEcCtD
Melphalan—Connective tissue disorder—Mycophenolate mofetil—systemic scleroderma	0.00117	0.00123	CcSEcCtD
Melphalan—Urethral disorder—Mycophenolate mofetil—systemic scleroderma	0.00116	0.00123	CcSEcCtD
Melphalan—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00116	0.00123	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00116	0.00122	CcSEcCtD
Melphalan—Skin disorder—Azathioprine—systemic scleroderma	0.00115	0.00122	CcSEcCtD
Melphalan—Cough—Mycophenolic acid—systemic scleroderma	0.00114	0.00121	CcSEcCtD
Melphalan—Vomiting—Pentoxifylline—systemic scleroderma	0.00114	0.0012	CcSEcCtD
Melphalan—Convulsion—Mycophenolic acid—systemic scleroderma	0.00113	0.0012	CcSEcCtD
Melphalan—Rash—Pentoxifylline—systemic scleroderma	0.00113	0.00119	CcSEcCtD
Melphalan—Dermatitis—Pentoxifylline—systemic scleroderma	0.00113	0.00119	CcSEcCtD
Melphalan—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00112	0.00118	CcSEcCtD
Melphalan—Chest pain—Mycophenolic acid—systemic scleroderma	0.00111	0.00118	CcSEcCtD
Melphalan—Myalgia—Mycophenolic acid—systemic scleroderma	0.00111	0.00118	CcSEcCtD
Melphalan—Infection—Leflunomide—systemic scleroderma	0.00111	0.00117	CcSEcCtD
Melphalan—Asthenia—Mometasone—systemic scleroderma	0.00111	0.00117	CcSEcCtD
Melphalan—Hypotension—Azathioprine—systemic scleroderma	0.00111	0.00117	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.00111	0.00117	CcSEcCtD
Melphalan—Cardiac arrest—Prednisone—systemic scleroderma	0.00111	0.00117	CcSEcCtD
Melphalan—Thrombocytopenia—Leflunomide—systemic scleroderma	0.0011	0.00116	CcSEcCtD
Melphalan—Pruritus—Mometasone—systemic scleroderma	0.00109	0.00116	CcSEcCtD
Melphalan—Tachycardia—Leflunomide—systemic scleroderma	0.00109	0.00115	CcSEcCtD
Melphalan—Anaemia—Lisinopril—systemic scleroderma	0.00109	0.00115	CcSEcCtD
Melphalan—Skin disorder—Leflunomide—systemic scleroderma	0.00109	0.00115	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00108	0.00114	CcSEcCtD
Melphalan—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00113	CcSEcCtD
Melphalan—Oedema—Mycophenolic acid—systemic scleroderma	0.00107	0.00113	CcSEcCtD
Melphalan—Anorexia—Leflunomide—systemic scleroderma	0.00107	0.00113	CcSEcCtD
Melphalan—Nausea—Pentoxifylline—systemic scleroderma	0.00106	0.00112	CcSEcCtD
Melphalan—Infection—Mycophenolic acid—systemic scleroderma	0.00106	0.00112	CcSEcCtD
Melphalan—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.00106	0.00112	CcSEcCtD
Melphalan—Diarrhoea—Mometasone—systemic scleroderma	0.00106	0.00112	CcSEcCtD
Melphalan—Leukopenia—Lisinopril—systemic scleroderma	0.00105	0.00111	CcSEcCtD
Melphalan—Renal failure acute—Methotrexate—systemic scleroderma	0.00105	0.00111	CcSEcCtD
Melphalan—Alopecia—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00111	CcSEcCtD
Melphalan—Hypotension—Leflunomide—systemic scleroderma	0.00105	0.0011	CcSEcCtD
Melphalan—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00105	0.0011	CcSEcCtD
Melphalan—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00104	0.0011	CcSEcCtD
Melphalan—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00104	0.0011	CcSEcCtD
Melphalan—Cough—Lisinopril—systemic scleroderma	0.00103	0.00109	CcSEcCtD
Melphalan—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00102	0.00108	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.00102	0.00108	CcSEcCtD
Melphalan—Anorexia—Mycophenolic acid—systemic scleroderma	0.00102	0.00108	CcSEcCtD
Melphalan—Paraesthesia—Leflunomide—systemic scleroderma	0.00101	0.00106	CcSEcCtD
Melphalan—Chest pain—Lisinopril—systemic scleroderma	0.001	0.00106	CcSEcCtD
Melphalan—Myalgia—Lisinopril—systemic scleroderma	0.001	0.00106	CcSEcCtD
Melphalan—Dyspnoea—Leflunomide—systemic scleroderma	0.000998	0.00105	CcSEcCtD
Melphalan—Hypotension—Mycophenolic acid—systemic scleroderma	0.000998	0.00105	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000996	0.00105	CcSEcCtD
Melphalan—Dyspepsia—Leflunomide—systemic scleroderma	0.000985	0.00104	CcSEcCtD
Melphalan—Vomiting—Mometasone—systemic scleroderma	0.000983	0.00104	CcSEcCtD
Melphalan—Rash—Mometasone—systemic scleroderma	0.000975	0.00103	CcSEcCtD
Melphalan—Asthenia—Captopril—systemic scleroderma	0.000974	0.00103	CcSEcCtD
Melphalan—Dermatitis—Mometasone—systemic scleroderma	0.000974	0.00103	CcSEcCtD
Melphalan—Decreased appetite—Leflunomide—systemic scleroderma	0.000973	0.00103	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000973	0.00103	CcSEcCtD
Melphalan—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000966	0.00102	CcSEcCtD
Melphalan—Fatigue—Leflunomide—systemic scleroderma	0.000965	0.00102	CcSEcCtD
Melphalan—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000962	0.00102	CcSEcCtD
Melphalan—Oedema—Lisinopril—systemic scleroderma	0.000962	0.00102	CcSEcCtD
Melphalan—Pruritus—Captopril—systemic scleroderma	0.000961	0.00101	CcSEcCtD
Melphalan—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000959	0.00101	CcSEcCtD
Melphalan—Pain—Leflunomide—systemic scleroderma	0.000957	0.00101	CcSEcCtD
Melphalan—Infection—Lisinopril—systemic scleroderma	0.000956	0.00101	CcSEcCtD
Melphalan—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000954	0.00101	CcSEcCtD
Melphalan—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000952	0.00101	CcSEcCtD
Melphalan—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000942	0.000995	CcSEcCtD
Melphalan—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00094	0.000993	CcSEcCtD
Melphalan—Neutropenia—Prednisone—systemic scleroderma	0.000939	0.000992	CcSEcCtD
Melphalan—Tachycardia—Lisinopril—systemic scleroderma	0.000939	0.000992	CcSEcCtD
Melphalan—Skin disorder—Lisinopril—systemic scleroderma	0.000934	0.000987	CcSEcCtD
Melphalan—Diarrhoea—Captopril—systemic scleroderma	0.000929	0.000982	CcSEcCtD
Melphalan—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000928	0.000981	CcSEcCtD
Melphalan—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000924	0.000976	CcSEcCtD
Melphalan—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000922	0.000974	CcSEcCtD
Melphalan—Fatigue—Mycophenolic acid—systemic scleroderma	0.000921	0.000972	CcSEcCtD
Melphalan—Nausea—Mometasone—systemic scleroderma	0.000919	0.00097	CcSEcCtD
Melphalan—Anorexia—Lisinopril—systemic scleroderma	0.000917	0.000968	CcSEcCtD
Melphalan—Pain—Mycophenolic acid—systemic scleroderma	0.000913	0.000965	CcSEcCtD
Melphalan—Cough—Mycophenolate mofetil—systemic scleroderma	0.000901	0.000952	CcSEcCtD
Melphalan—Hypotension—Lisinopril—systemic scleroderma	0.000899	0.000949	CcSEcCtD
Melphalan—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000897	0.000947	CcSEcCtD
Melphalan—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000895	0.000945	CcSEcCtD
Melphalan—Urticaria—Leflunomide—systemic scleroderma	0.000889	0.000939	CcSEcCtD
Melphalan—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000879	0.000929	CcSEcCtD
Melphalan—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000879	0.000929	CcSEcCtD
Melphalan—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000878	0.000927	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000876	0.000926	CcSEcCtD
Melphalan—Hypersensitivity—Azathioprine—systemic scleroderma	0.000873	0.000922	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000873	0.000922	CcSEcCtD
Melphalan—Paraesthesia—Lisinopril—systemic scleroderma	0.000864	0.000912	CcSEcCtD
Melphalan—Vomiting—Captopril—systemic scleroderma	0.000864	0.000912	CcSEcCtD
Melphalan—Dyspnoea—Lisinopril—systemic scleroderma	0.000858	0.000906	CcSEcCtD
Melphalan—Rash—Captopril—systemic scleroderma	0.000856	0.000905	CcSEcCtD
Melphalan—Dermatitis—Captopril—systemic scleroderma	0.000856	0.000904	CcSEcCtD
Melphalan—Dyspepsia—Lisinopril—systemic scleroderma	0.000847	0.000894	CcSEcCtD
Melphalan—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000843	0.00089	CcSEcCtD
Melphalan—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000843	0.00089	CcSEcCtD
Melphalan—Infection—Mycophenolate mofetil—systemic scleroderma	0.000837	0.000884	CcSEcCtD
Melphalan—Decreased appetite—Lisinopril—systemic scleroderma	0.000836	0.000883	CcSEcCtD
Melphalan—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00083	0.000877	CcSEcCtD
Melphalan—Fatigue—Lisinopril—systemic scleroderma	0.000829	0.000876	CcSEcCtD
Melphalan—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000825	0.000872	CcSEcCtD
Melphalan—Hypersensitivity—Leflunomide—systemic scleroderma	0.000825	0.000871	CcSEcCtD
Melphalan—Pain—Lisinopril—systemic scleroderma	0.000823	0.000869	CcSEcCtD
Melphalan—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000823	0.000869	CcSEcCtD
Melphalan—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000819	0.000865	CcSEcCtD
Melphalan—Diarrhoea—Azathioprine—systemic scleroderma	0.000811	0.000857	CcSEcCtD
Melphalan—Haemoglobin—Prednisone—systemic scleroderma	0.000808	0.000854	CcSEcCtD
Melphalan—Nausea—Captopril—systemic scleroderma	0.000807	0.000852	CcSEcCtD
Melphalan—Haemorrhage—Prednisone—systemic scleroderma	0.000804	0.000849	CcSEcCtD
Melphalan—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000803	0.000849	CcSEcCtD
Melphalan—Asthenia—Leflunomide—systemic scleroderma	0.000803	0.000848	CcSEcCtD
Melphalan—Pancytopenia—Methotrexate—systemic scleroderma	0.000797	0.000842	CcSEcCtD
Melphalan—Pruritus—Leflunomide—systemic scleroderma	0.000792	0.000837	CcSEcCtD
Melphalan—Connective tissue disorder—Prednisone—systemic scleroderma	0.00079	0.000835	CcSEcCtD
Melphalan—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000787	0.000832	CcSEcCtD
Melphalan—Neutropenia—Methotrexate—systemic scleroderma	0.000785	0.000829	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000768	0.000811	CcSEcCtD
Melphalan—Asthenia—Mycophenolic acid—systemic scleroderma	0.000766	0.000809	CcSEcCtD
Melphalan—Diarrhoea—Leflunomide—systemic scleroderma	0.000766	0.000809	CcSEcCtD
Melphalan—Urticaria—Lisinopril—systemic scleroderma	0.000764	0.000807	CcSEcCtD
Melphalan—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000757	0.000799	CcSEcCtD
Melphalan—Pruritus—Mycophenolic acid—systemic scleroderma	0.000756	0.000798	CcSEcCtD
Melphalan—Vomiting—Azathioprine—systemic scleroderma	0.000754	0.000796	CcSEcCtD
Melphalan—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000751	0.000794	CcSEcCtD
Melphalan—Rash—Azathioprine—systemic scleroderma	0.000747	0.000789	CcSEcCtD
Melphalan—Dermatitis—Azathioprine—systemic scleroderma	0.000747	0.000789	CcSEcCtD
Melphalan—Flushing—Prednisone—systemic scleroderma	0.000746	0.000788	CcSEcCtD
Melphalan—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000742	0.000784	CcSEcCtD
Melphalan—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000733	0.000774	CcSEcCtD
Melphalan—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000731	0.000772	CcSEcCtD
Melphalan—Stomatitis—Methotrexate—systemic scleroderma	0.00073	0.000771	CcSEcCtD
Melphalan—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000728	0.000769	CcSEcCtD
Melphalan—Immune system disorder—Prednisone—systemic scleroderma	0.000726	0.000767	CcSEcCtD
Melphalan—Pain—Mycophenolate mofetil—systemic scleroderma	0.000721	0.000761	CcSEcCtD
Melphalan—Arrhythmia—Prednisone—systemic scleroderma	0.000718	0.000759	CcSEcCtD
Melphalan—Vomiting—Leflunomide—systemic scleroderma	0.000712	0.000752	CcSEcCtD
Melphalan—Alopecia—Prednisone—systemic scleroderma	0.000711	0.00075	CcSEcCtD
Melphalan—Hypersensitivity—Lisinopril—systemic scleroderma	0.000709	0.000749	CcSEcCtD
Melphalan—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000708	0.000748	CcSEcCtD
Melphalan—Rash—Leflunomide—systemic scleroderma	0.000706	0.000746	CcSEcCtD
Melphalan—Dermatitis—Leflunomide—systemic scleroderma	0.000705	0.000745	CcSEcCtD
Melphalan—Nausea—Azathioprine—systemic scleroderma	0.000704	0.000744	CcSEcCtD
Melphalan—Asthenia—Lisinopril—systemic scleroderma	0.00069	0.000729	CcSEcCtD
Melphalan—Pruritus—Lisinopril—systemic scleroderma	0.000681	0.000719	CcSEcCtD
Melphalan—Vomiting—Mycophenolic acid—systemic scleroderma	0.000679	0.000717	CcSEcCtD
Melphalan—Haemoglobin—Methotrexate—systemic scleroderma	0.000675	0.000713	CcSEcCtD
Melphalan—Rash—Mycophenolic acid—systemic scleroderma	0.000673	0.000711	CcSEcCtD
Melphalan—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000673	0.000711	CcSEcCtD
Melphalan—Haemorrhage—Methotrexate—systemic scleroderma	0.000672	0.00071	CcSEcCtD
Melphalan—Hepatitis—Methotrexate—systemic scleroderma	0.000672	0.00071	CcSEcCtD
Melphalan—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00067	0.000707	CcSEcCtD
Melphalan—Nausea—Leflunomide—systemic scleroderma	0.000665	0.000702	CcSEcCtD
Melphalan—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000664	0.000701	CcSEcCtD
Melphalan—Urethral disorder—Methotrexate—systemic scleroderma	0.000659	0.000696	CcSEcCtD
Melphalan—Diarrhoea—Lisinopril—systemic scleroderma	0.000658	0.000695	CcSEcCtD
Melphalan—Anaemia—Prednisone—systemic scleroderma	0.000647	0.000683	CcSEcCtD
Melphalan—Nausea—Mycophenolic acid—systemic scleroderma	0.000634	0.00067	CcSEcCtD
Melphalan—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000621	0.000656	CcSEcCtD
Melphalan—Vomiting—Lisinopril—systemic scleroderma	0.000612	0.000646	CcSEcCtD
Melphalan—Immune system disorder—Methotrexate—systemic scleroderma	0.000607	0.000641	CcSEcCtD
Melphalan—Rash—Lisinopril—systemic scleroderma	0.000606	0.000641	CcSEcCtD
Melphalan—Convulsion—Prednisone—systemic scleroderma	0.000606	0.000641	CcSEcCtD
Melphalan—Dermatitis—Lisinopril—systemic scleroderma	0.000606	0.00064	CcSEcCtD
Melphalan—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000606	0.00064	CcSEcCtD
Melphalan—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000605	0.000639	CcSEcCtD
Melphalan—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000596	0.00063	CcSEcCtD
Melphalan—Myalgia—Prednisone—systemic scleroderma	0.000596	0.000629	CcSEcCtD
Melphalan—Alopecia—Methotrexate—systemic scleroderma	0.000594	0.000627	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000592	0.000625	CcSEcCtD
Melphalan—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000577	0.000609	CcSEcCtD
Melphalan—Nausea—Lisinopril—systemic scleroderma	0.000571	0.000603	CcSEcCtD
Melphalan—Anaphylactic shock—Prednisone—systemic scleroderma	0.000571	0.000603	CcSEcCtD
Melphalan—Oedema—Prednisone—systemic scleroderma	0.000571	0.000603	CcSEcCtD
Melphalan—Infection—Prednisone—systemic scleroderma	0.000568	0.000599	CcSEcCtD
Melphalan—Tachycardia—Prednisone—systemic scleroderma	0.000558	0.000589	CcSEcCtD
Melphalan—Skin disorder—Prednisone—systemic scleroderma	0.000555	0.000586	CcSEcCtD
Melphalan—Anorexia—Prednisone—systemic scleroderma	0.000545	0.000575	CcSEcCtD
Melphalan—Anaemia—Methotrexate—systemic scleroderma	0.000541	0.000571	CcSEcCtD
Melphalan—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000536	0.000566	CcSEcCtD
Melphalan—Rash—Mycophenolate mofetil—systemic scleroderma	0.000531	0.000561	CcSEcCtD
Melphalan—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000531	0.000561	CcSEcCtD
Melphalan—Leukopenia—Methotrexate—systemic scleroderma	0.000524	0.000553	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00052	0.00055	CcSEcCtD
Melphalan—Paraesthesia—Prednisone—systemic scleroderma	0.000513	0.000542	CcSEcCtD
Melphalan—Cough—Methotrexate—systemic scleroderma	0.00051	0.000539	CcSEcCtD
Melphalan—Convulsion—Methotrexate—systemic scleroderma	0.000507	0.000535	CcSEcCtD
Melphalan—Dyspepsia—Prednisone—systemic scleroderma	0.000503	0.000531	CcSEcCtD
Melphalan—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000501	0.000529	CcSEcCtD
Melphalan—Myalgia—Methotrexate—systemic scleroderma	0.000498	0.000526	CcSEcCtD
Melphalan—Chest pain—Methotrexate—systemic scleroderma	0.000498	0.000526	CcSEcCtD
Melphalan—Decreased appetite—Prednisone—systemic scleroderma	0.000497	0.000525	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000495	0.000522	CcSEcCtD
Melphalan—Fatigue—Prednisone—systemic scleroderma	0.000493	0.00052	CcSEcCtD
Melphalan—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000477	0.000504	CcSEcCtD
Melphalan—Infection—Methotrexate—systemic scleroderma	0.000474	0.000501	CcSEcCtD
Melphalan—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000467	0.000494	CcSEcCtD
Melphalan—Skin disorder—Methotrexate—systemic scleroderma	0.000464	0.00049	CcSEcCtD
Melphalan—Anorexia—Methotrexate—systemic scleroderma	0.000455	0.000481	CcSEcCtD
Melphalan—Urticaria—Prednisone—systemic scleroderma	0.000454	0.000479	CcSEcCtD
Melphalan—Hypotension—Methotrexate—systemic scleroderma	0.000446	0.000471	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000435	0.000459	CcSEcCtD
Melphalan—Paraesthesia—Methotrexate—systemic scleroderma	0.000429	0.000453	CcSEcCtD
Melphalan—Dyspnoea—Methotrexate—systemic scleroderma	0.000426	0.00045	CcSEcCtD
Melphalan—Hypersensitivity—Prednisone—systemic scleroderma	0.000421	0.000445	CcSEcCtD
Melphalan—Dyspepsia—Methotrexate—systemic scleroderma	0.00042	0.000444	CcSEcCtD
Melphalan—Decreased appetite—Methotrexate—systemic scleroderma	0.000415	0.000438	CcSEcCtD
Melphalan—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000412	0.000435	CcSEcCtD
Melphalan—Fatigue—Methotrexate—systemic scleroderma	0.000412	0.000435	CcSEcCtD
Melphalan—Asthenia—Prednisone—systemic scleroderma	0.00041	0.000433	CcSEcCtD
Melphalan—Pain—Methotrexate—systemic scleroderma	0.000408	0.000431	CcSEcCtD
Melphalan—Pruritus—Prednisone—systemic scleroderma	0.000404	0.000427	CcSEcCtD
Melphalan—Diarrhoea—Prednisone—systemic scleroderma	0.000391	0.000413	CcSEcCtD
Melphalan—Urticaria—Methotrexate—systemic scleroderma	0.000379	0.000401	CcSEcCtD
Melphalan—Vomiting—Prednisone—systemic scleroderma	0.000363	0.000384	CcSEcCtD
Melphalan—Rash—Prednisone—systemic scleroderma	0.00036	0.00038	CcSEcCtD
Melphalan—Dermatitis—Prednisone—systemic scleroderma	0.00036	0.00038	CcSEcCtD
Melphalan—Hypersensitivity—Methotrexate—systemic scleroderma	0.000352	0.000372	CcSEcCtD
Melphalan—Asthenia—Methotrexate—systemic scleroderma	0.000343	0.000362	CcSEcCtD
Melphalan—Nausea—Prednisone—systemic scleroderma	0.000339	0.000358	CcSEcCtD
Melphalan—Pruritus—Methotrexate—systemic scleroderma	0.000338	0.000357	CcSEcCtD
Melphalan—Diarrhoea—Methotrexate—systemic scleroderma	0.000327	0.000345	CcSEcCtD
Melphalan—Vomiting—Methotrexate—systemic scleroderma	0.000304	0.000321	CcSEcCtD
Melphalan—Rash—Methotrexate—systemic scleroderma	0.000301	0.000318	CcSEcCtD
Melphalan—Dermatitis—Methotrexate—systemic scleroderma	0.000301	0.000318	CcSEcCtD
Melphalan—Nausea—Methotrexate—systemic scleroderma	0.000284	0.0003	CcSEcCtD
